-
Substance P: Analytical Controls for Better Research
2026-09-10
Substance P is more than a pain-model agonist: it is a precise tool for studying neuroimmune signaling when identity, handling, and assay interference are controlled. This guide connects NK-1 biology with lessons from modern fluorescence-spectroscopy quality control.
-
Concanamycin A: Reliable V-ATPase Assays
2026-09-10
Learn how Concanamycin A (SKU A8633) can improve the interpretation and reproducibility of cell viability, apoptosis, trafficking, and invasion experiments. This scenario-based guide connects concentration, vehicle, timing, controls, and product-format decisions to evidence-informed cancer biology workflows.
-
HACC-TNF-α-VLPs Enhance FMDV Cross-Presentation
2026-09-09
This 2026 study developed HACC-TNF-α-VLP nanoparticles that improved dendritic-cell antigen cross-presentation through an HSP90-associated mechanism. In mice, the formulation strengthened CD8+ T-cell, tissue-resident memory, mucosal IgA, and systemic antibody responses, providing a technically informative framework for next-generation foot-and-mouth disease vaccines.
-
TG003 and CLK2: From Splicing to Translation
2026-09-09
TG003 offers a mechanistically useful bridge between Clk-dependent splicing control and CLK2-linked platinum resistance. This thought-leadership guide outlines how translational researchers can use the compound to separate kinase, splicing, and DNA-repair hypotheses without overstating a research tool as a clinical therapy.
-
Mifepristone (RU486): From PR Antagonism to Translation
2026-09-08
Mifepristone (RU486) is more than a progesterone receptor antagonist: it is a mechanistic probe for connecting hormone-receptor context, cell-cycle control, ferroptosis, and reproductive biology. This thought-leadership analysis outlines how translational researchers can use the compound strategically while distinguishing established evidence from hypothesis-generating opportunities.
-
Nirmatrelvir (PF-07321332) Lab Assays
2026-09-08
Learn how Nirmatrelvir (PF-07321332), SKU B8579, can support reproducible SARS-CoV-2 protease and cell-based antiviral experiments. This scenario-driven guide covers assay interpretation, solvent compatibility, stock preparation, controls, and practical supplier selection.
-
Capsaicin as a KDM1A/LSD1 Inhibitor
2026-09-07
Jia and colleagues identified Capsaicin as a reversible, FAD-competitive inhibitor of lysine-specific demethylase 1A (KDM1A/LSD1), extending the biological scope of this dietary vanillamide beyond sensory pharmacology. In gastric cancer cells, the study connected KDM1A inhibition with reduced migration and invasion and reversal of epithelial–mesenchymal transition, while also highlighting important limits for target validation and cross-domain interpretation.
-
Azithromycin: Resistance-Aware Assay Design
2026-09-07
Azithromycin is more than a conventional macrolide antibiotic: its assay performance depends on resistance genotype, matrix, concentration, and analytical endpoint. This guide translates recent Mycoplasma pneumoniae findings into a practical framework for bacterial infection research, quality control, and model selection.
-
SN-38 Beyond TOP1: A Translational Research Playbook
2026-09-05
7-Ethyl-10-hydroxycamptothecin, also known as SN-38, offers translational researchers a way to connect DNA topoisomerase I trapping, cell-cycle disruption, apoptosis, and FUBP1-FUSE biology. This article outlines how to validate that mechanistic stack in advanced colon cancer research while maintaining clear boundaries between preclinical evidence and clinical interpretation.
-
Nirmatrelvir: An Assay-Design Benchmark
2026-09-04
Nirmatrelvir (PF-07321332) provides a mechanistically defined benchmark for SARS-CoV-2 3CL protease studies. This article explains how to use it to connect biochemical inhibition, coronavirus infection models, and defensible antiviral therapeutics research decisions.
-
Amorolfine Hydrochloride in Yeast Research
2026-09-04
Use Amorolfine Hydrochloride as a controlled membrane-stress probe in yeast ploidy, cell-integrity, and antifungal resistance experiments. This workflow connects chemical perturbation with the 32–64C ploidy boundary reported in budding yeast while separating growth inhibition from direct membrane phenotypes.
-
ddATP: Practical DNA Synthesis Termination Workflows
2026-09-03
ddATP gives researchers a controllable way to terminate DNA synthesis, from defined polymerase assays and Sanger sequencing to damage-amplification studies in oocytes. This guide translates its competitive chain-termination mechanism into practical workflows, quantitative starting conditions, and troubleshooting strategies.
-
Prednisone Workflows for Immunology Research
2026-09-03
Build more reproducible Prednisone assays by pairing controlled DMSO handling with time-resolved lymphocyte phenotyping. This guide also shows how digestion-inspired LC–MS/MS quality controls can strengthen immunosuppression, apoptosis, and neurodegeneration workflows without overstating translational evidence.
-
3-Deazaneplanocin (DZNep) Experimental Workflows
2026-09-02
Learn how to deploy 3-Deazaneplanocin (DZNep) in AML apoptosis studies, hepatocellular carcinoma sphere assays, and epigenetic profiling. Practical dose design, controls, and troubleshooting help distinguish EZH2-linked effects from broader SAHH-dependent cellular responses.
-
ATP Solution for IVT and Kinase Workflows
2026-09-02
A practical guide to using ATP Solution (100 mM) in kinase, in vitro transcription, ligation, and phosphorylation workflows. Learn how controlled ATP handling supports the upstream production of research-grade mRNA while keeping interpretation of downstream lipid nanoparticle studies evidence-based.